TG Therapeutics Inc (TGTX)
Financial leverage ratio
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Total assets | US$ in thousands | 329,587 | 193,572 | 379,629 | 625,642 | 163,014 |
| Total stockholders’ equity | US$ in thousands | 160,502 | 58,587 | 237,153 | 519,350 | 38,615 |
| Financial leverage ratio | 2.05 | 3.30 | 1.60 | 1.20 | 4.22 |
December 31, 2023 calculation
Financial leverage ratio = Total assets ÷ Total stockholders’ equity
= $329,587K ÷ $160,502K
= 2.05
The financial leverage ratio for TG Therapeutics Inc has shown variability in recent years. In 2023, the ratio stood at 2.05, indicating that the company's level of debt relative to its equity was moderate. This represents a decrease from the previous year, where the ratio was 3.30, suggesting a higher level of leverage.
In 2021, the financial leverage ratio was 1.60, reflecting a relatively lower level of debt compared to equity. This ratio increased to 1.20 in 2020, indicating a slight rise in leverage. The highest financial leverage ratio in the given period was in 2019 at 4.22, signifying a significant proportion of debt in the company's capital structure.
Overall, the financial leverage ratio for TG Therapeutics Inc has fluctuated over the years, potentially indicating changes in the company's capital structure and risk profile. Investors and stakeholders may need to monitor these fluctuations to assess the company's financial health and risk exposure.
Peer comparison
Dec 31, 2023